We are live on ! Find out more
Hudson Bay Capital Management

Hudson Bay Capital Management Portfolio holdings

AUM $36.8B
1-Year Est. Return 42.13%
This Fund
S&P 500
This Quarter Est. Return
+25.38%
1 Year Est. Return
+42.13%
3 Year Est. Return
+132.25%
5 Year Est. Return
+176.99%
10 Year Est. Return
+617.55%
AUM
$36.8B
AUM Growth
+$7.85B
Cap. Flow
+$595M
Cap. Flow %
1.61%
Top 10 Hldgs %
25.79%
Holding
1,853
New
472
Increased
265
Reduced
308
Closed
518

Top Buys

Rank Stock Value
1
TSM icon
TSMC
TSM
+$494M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$450M
3
SNDK
Sandisk
SNDK
+$437M
4
PLTR icon
Palantir
PLTR
+$400M
5
AMZN icon
Amazon
AMZN
+$293M

Sector Composition

Rank Sector Weight
1 Miscellaneous 49.87%
2 Technology 15.36%
3 Financials 7.19%
4 Consumer Discretionary 6.62%
5 Communication Services 5.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACVA icon
1326
ACV Auctions
ACVA
$1.78B
– –
-292,903
Closed -$1.24M
AFL icon
1327
Aflac
AFL
$57B
– –
-4,000
Closed -$439K
AGEN
1328
Agenus
AGEN
$386M
– –
-33,543
Closed -$112K
AGNC icon
1329
AGNC Investment
AGNC
$11.4B
– –
-214,285
Closed -$2.15M
AIR icon
1330
AAR Corp
AIR
$4.67B
– –
-58,585
Closed -$6.41M
ALC icon
1331
Alcon
ALC
$31.2B
– –
-30,000
Closed -$2.26M
ALHC icon
1332
Alignment Healthcare
ALHC
$1.7B
– –
-120,250
Closed -$2.12M
ALK icon
1333
Alaska Air
ALK
$4.57B
– –
-18,000
Closed -$662K
ALKS icon
1334
Alkermes
ALKS
$6.85B
– –
-173,626
Closed -$6.14M
ALLE icon
1335
Allegion
ALLE
$13.1B
– –
-13,000
Closed -$1.89M
ALLO icon
1336
Allogene Therapeutics
ALLO
$570M
– –
-14,711
Closed -$35.9K
ALTO icon
1337
Alto Ingredients
ALTO
$289M
– –
-48,898
Closed -$237K
AMAT icon
1338
Applied Materials
AMAT
$385B
– –
-11,571
Closed -$3.95M
AMPX.WS icon
1339
Amprius Technologies Warrants
AMPX.WS
$380M
– –
-741,715
Closed -$5.1M
AMPY icon
1340
Amplify Energy
AMPY
$177M
– –
-59,159
Closed -$369K
AMRX icon
1341
Amneal Pharmaceuticals
AMRX
$6.89B
– –
-12,010
Closed -$149K
AMTX icon
1342
Aemetis
AMTX
$129M
– –
-106,836
Closed -$341K
ANTX icon
1343
AN2 Therapeutics
ANTX
$184M
– –
-34,605
Closed -$118K
AP icon
1344
Ampco-Pittsburgh
AP
$178M
– –
-27,112
Closed -$182K
APGE
1345
DELISTED
Apogee Therapeutics
APGE
– –
-5,720
Closed -$481K
APH icon
1346
Amphenol
APH
$207B
– –
-24,114
Closed -$1.52M
APLS
1347
DELISTED
Apellis Pharmaceuticals
APLS
– –
-1,190,416
Closed -$47.9M
APYX icon
1348
Apyx Medical
APYX
$125M
– –
-54,001
Closed -$199K
AREC icon
1349
American Resources Corp
AREC
$203M
– –
-60,180
Closed -$146K
ARKG icon
1350
ARK Genomic Revolution ETF
ARKG
$2.15B
– –
-50,000
Closed -$1.32M

Similar funds

Hudson Bay Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Hudson Bay Capital Management held 1,853 positions worth $36.8B, up 27% from $29B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Hudson Bay Capital Management's Q2 2026 filing shows 472 new, 265 increased, 308 reduced and 518 closed positions. Its largest new stake was Sandisk: 306,118 shares worth $696M. The largest sale was Apple, an estimated $403M.

By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, down from 51% a quarter earlier, followed by Technology and Financials.

  • Hudson Bay Capital Management's largest Q2 2026 buy was Sandisk: 306,118 shares worth $696M.
  • Hudson Bay Capital Management added most to TSMC in Q2 2026, an estimated $494M increase.
  • Hudson Bay Capital Management's biggest Q2 2026 reduction was Apple, cutting an estimated $403M.
  • Hudson Bay Capital Management fully exited Broadcom in Q2 2026, selling an estimated $200M.
  • Hudson Bay Capital Management's ten largest holdings make up 26% of its $36.8B portfolio in Q2 2026.
  • Hudson Bay Capital Management opened 472 new positions and closed 518 in Q2 2026.
  • Hudson Bay Capital Management's portfolio value rose 27% quarter-over-quarter to $36.8B.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.